Depakene-R



Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 26.8%
Epilepsy 26.4%
Frontal Lobe Epilepsy 10.4%
Bipolar I Disorder 5.9%
Hypertension 5.6%
Constipation 3.3%
Bipolar Ii Disorder 2.6%
Partial Seizures 2.6%
Depressed Mood 2.2%
Infantile Spasms 2.2%
Restlessness 1.9%
Asthma 1.5%
Diabetes Mellitus 1.5%
Insomnia 1.5%
Depression 1.1%
Gastrooesophageal Reflux Disease 1.1%
Schizophrenia 1.1%
Cerebral Infarction 0.7%
Dementia 0.7%
Glomerulonephritis Chronic 0.7%
Rash 14.3%
Platelet Count Decreased 8.6%
Prostatitis 8.6%
White Blood Cell Count Increased 8.6%
Drug Reaction With Eosinophilia And Systemic Symptoms 5.7%
Overdose 5.7%
Pneumonia 5.7%
Sepsis 5.7%
Stevens-johnson Syndrome 5.7%
Blood Creatinine Increased 2.9%
Brain Contusion 2.9%
Epilepsy 2.9%
Haemorrhage Subcutaneous 2.9%
Inappropriate Antidiuretic Hormone Secretion 2.9%
Maternal Exposure During Pregnancy 2.9%
Pre-eclampsia 2.9%
Pyrexia 2.9%
Rash Papular 2.9%
Renal Impairment 2.9%
Reticulocyte Count Decreased 2.9%
Concomitant
Simple Partial Seizures 17.2%
Complex Partial Seizures 16.9%
Epilepsy 15.6%
Partial Seizures With Secondary Generalisation 15.6%
Product Used For Unknown Indication 5.2%
Bipolar Disorder 3.7%
Schizophrenia, Paranoid Type 2.6%
Grand Mal Convulsion 2.5%
Insomnia 2.5%
Depression 2.4%
Substance-induced Psychotic Disorder 2.2%
Sleep Disorder 2.0%
Schizophrenia 1.9%
Bipolar I Disorder 1.8%
Prophylaxis 1.6%
Schizophrenia, Disorganised Type 1.5%
Constipation 1.2%
Hypertension 1.2%
Juvenile Idiopathic Arthritis 1.2%
Metastatic Renal Cell Carcinoma 1.1%
Ileus 24.3%
Loss Of Consciousness 6.8%
Rash 6.8%
White Blood Cell Count Increased 6.8%
Pyrexia 5.4%
Tremor 5.4%
White Blood Cell Count Decreased 5.4%
Skin Disorder 4.1%
Suicide Attempt 4.1%
Urinary Tract Infection 4.1%
Completed Suicide 2.7%
Lung Neoplasm Malignant 2.7%
Pneumonia 2.7%
Rash Generalised 2.7%
Schizophrenia 2.7%
Status Epilepticus 2.7%
Stevens-johnson Syndrome 2.7%
Swelling Face 2.7%
Thrombocytopenia 2.7%
Torticollis 2.7%